An update on knowledge graphs and their current and potential applications in drug discovery.

An update on knowledge graphs and their current and potential applications in drug discovery.

Publication date: Apr 14, 2025

Knowledge graphs are becoming prominent tools in computational drug discovery. They effectively integrate heterogeneous biomedical data and generate new hypotheses and knowledge. This article is based on a literature review using Google Scholar and PubMed to retrieve articles on existing knowledge graphs relevant to the drug discovery field. The authors compare the types of entities, relationships, and data sources they encompass. Additionally, the authors provide examples of their use in the drug discovery field and discuss potential strategies for advancing this research area. Knowledge graphs are crucial in drug discovery, but their construction leads to challenges in data integration and consistency. Future research should prioritize the standardization of data sources and data modeling. More efforts are needed for the integration in knowledge graphs of diverse data types, such as chemical structures and epigenetic data, to enhance their effectiveness. Additionally, advancements in large language models should be pursued to aid the development of knowledge graphs, provide intuitive querying capabilities for non-expert users, and explain knowledge graphs -derived predictions, thereby making these tools more accessible and their insights more interpretable for a wider audience.

Open Access PDF

Concepts Keywords
Biomedical drug discovery
Discov knowledge extraction
Expert Knowledge graphs (KGs)
Google link prediction
Graphs

Semantics

Type Source Name
disease MESH data sources
drug DRUGBANK Coenzyme M
drug DRUGBANK Abacavir
drug DRUGBANK Huperzine B
drug DRUGBANK Trestolone
disease MESH adverse drug reactions
disease MESH tic
disease MESH drug interaction
drug DRUGBANK Tretamine
drug DRUGBANK Zinc
drug DRUGBANK Sulpiride
disease MESH nicotine addiction
disease MESH epilepsy
drug DRUGBANK Spinosad
disease MESH lung cancer
disease MESH rare diseases
drug DRUGBANK Timonacic
disease MESH pathogenesis
disease MESH COVID 19
drug DRUGBANK Ilex paraguariensis leaf
disease MESH nonalcoholic fatty liver disease
disease MESH aids
disease MESH privacy
disease MESH Intervertebral Disc Degeneration
disease MESH diabetes mellitus
disease MESH atrophic gastritis
drug DRUGBANK Resiniferatoxin
disease MESH syndrome
drug DRUGBANK Sulindac
drug DRUGBANK Ibudilast
disease MESH atopic dermatitis
drug DRUGBANK Epirubicin
drug DRUGBANK Paclitaxel
drug DRUGBANK Prednisone
disease MESH Alzheimer’s disease
drug DRUGBANK Warfarin
drug DRUGBANK Alpha-1-proteinase inhibitor
disease MESH uncertainty
drug DRUGBANK Diethylstilbestrol
drug DRUGBANK Guanosine
disease MESH hereditary disease
disease MESH complications
drug DRUGBANK Bean
drug DRUGBANK Aminosalicylic Acid

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *